JP2017525671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525671A5
JP2017525671A5 JP2017500060A JP2017500060A JP2017525671A5 JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5 JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
walton
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017500060A
Other languages
English (en)
Japanese (ja)
Other versions
JP6640826B2 (ja
JP2017525671A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/039444 external-priority patent/WO2016007554A1/en
Publication of JP2017525671A publication Critical patent/JP2017525671A/ja
Publication of JP2017525671A5 publication Critical patent/JP2017525671A5/ja
Application granted granted Critical
Publication of JP6640826B2 publication Critical patent/JP6640826B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017500060A 2014-07-08 2015-07-07 微粒子化ワルトン膠質 Active JP6640826B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022084P 2014-07-08 2014-07-08
US62/022,084 2014-07-08
PCT/US2015/039444 WO2016007554A1 (en) 2014-07-08 2015-07-07 Micronized wharton's jelly

Publications (3)

Publication Number Publication Date
JP2017525671A JP2017525671A (ja) 2017-09-07
JP2017525671A5 true JP2017525671A5 (enExample) 2018-08-16
JP6640826B2 JP6640826B2 (ja) 2020-02-05

Family

ID=55064792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500060A Active JP6640826B2 (ja) 2014-07-08 2015-07-07 微粒子化ワルトン膠質

Country Status (5)

Country Link
US (3) US20160008410A1 (enExample)
EP (1) EP3167049A4 (enExample)
JP (1) JP6640826B2 (enExample)
AU (1) AU2015287920A1 (enExample)
WO (1) WO2016007554A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104873956B (zh) 2005-09-27 2019-04-23 组织技术公司 羊膜制品和纯化的组合物及其使用方法
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
EP3297645A4 (en) 2015-05-20 2018-12-12 Tissuetech, Inc. Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
CN109219442A (zh) 2016-04-04 2019-01-15 Omeza有限公司 鱼油局部组合物
US10478531B2 (en) * 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
JP7684908B2 (ja) * 2019-04-16 2025-05-28 ライフネット ヘルス 出産組織由来の生成物並びにその調製及び使用
WO2022186946A1 (en) * 2021-03-03 2022-09-09 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
US20220280573A1 (en) * 2021-03-03 2022-09-08 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
WO2023164799A1 (zh) * 2022-03-01 2023-09-07 傅毓秀 可促进骨质新生的瓦顿氏凝胶制品

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5558071A (en) 1994-03-07 1996-09-24 Combustion Electromagnetics, Inc. Ignition system power converter and controller
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
EP1267912A2 (en) 2000-03-14 2003-01-02 Burkhard Göke Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
ES2672815T3 (es) * 2001-10-18 2018-06-18 Lifecell Corporation Remodelación de tejidos y órganos
EP1765266B1 (en) 2004-02-13 2011-04-13 Cognis France, S.A.S. Use of cosmetic compositions comprising an extract of the leaves of castanea sativa
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
US8105634B2 (en) 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
AU2007302586B2 (en) 2006-09-25 2013-06-27 Archer-Daniels-Midland Company Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
EP3689421B1 (en) 2007-09-07 2025-02-19 MiMedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
MX2011002936A (es) 2008-09-25 2011-04-11 Cephalon Inc Formulaciones liquidas de bendamustina.
BRPI0822802A2 (pt) * 2008-10-10 2015-09-01 Histocell Sl Biomaterial na forma de hidrogel injetável, biomaterial derivado do cordão umbilical humano, processo para a obtenção do biomaterial, processo para a obtenção do biomaterial obtido e uso do biomaterial
US20120141595A1 (en) 2009-08-25 2012-06-07 Tissuetech, Inc. Umbilical cord amniotic membrane products
CN102198292B (zh) 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
WO2012112410A2 (en) 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
KR20140107103A (ko) 2011-02-14 2014-09-04 미메딕스 그룹 인크. 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
JP5940095B2 (ja) * 2011-02-14 2016-06-29 ミメドックス グループ インコーポレーティッドＭｉｍｅｄｘ Ｇｒｏｕｐ Ｉｎｃ． ウォートン・ジェリーで構成されている積層組織移植片ならびにそれを作成および使用する方法
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
EP2736970A4 (en) * 2011-07-27 2015-05-13 Polyone Corp NETWORKABLE BIOWEAK MAKERS
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
JP6548897B2 (ja) 2011-12-30 2019-07-24 パテル、アミット 同種異系細胞の医療用途の誘導のための方法及び組成物並びに治療的利用
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
EP2884944B1 (en) 2012-08-15 2020-10-07 MiMedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
US10449220B2 (en) * 2013-08-30 2019-10-22 Mimedx Group, Inc. Micronized placental compositions comprising a chelator
WO2015179711A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160000968A1 (en) 2014-07-07 2016-01-07 Mimedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same

Similar Documents

Publication Publication Date Title
JP2017525671A5 (enExample)
Sharma et al. An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions
JP2017517255A5 (enExample)
AU2015287920A8 (en) Micronized Wharton's Jelly
MX384021B (es) Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones.
JP2014240439A5 (enExample)
JP2016504362A5 (enExample)
MX355611B (es) Formulaciones de anticuerpos monoclonales de alta concentracion.
MX2009012279A (es) Distribucion de micro y nanoparticulas con plaquetas.
WO2015050814A3 (en) Therapeutic agents for delivery using a catheter and pressure source
WO2014194254A8 (en) Treatment of cancers using pi3 kinase isoform modulators
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
PH12017500479B1 (en) Liquid inhalation formulation comprising rpl554
JP2014526447A5 (enExample)
BR112013027674A2 (pt) "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
AR064826A1 (es) Formulaciones de anticuerpos anti-il-13 y usos de los mismos. dispositivos, parche y jeringa
MX2014000141A (es) Agentes de enlace a receptor de canabinoide, composiciones y metodos.
IL294463A (en) Methods for treating or preventing eye conditions
JP2014218522A5 (enExample)
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
MX2015015589A (es) Composiciones y metodos para el suministro de agentes activos hidrófobos.
JP2013544781A5 (enExample)
WO2016095013A8 (en) Pharmaceutical composition comprising plasminogen and uses thereof
WO2014106116A3 (en) Therapeutic compositions comprising antibodies
MX390671B (es) Composicion de suspension oftalmica.